However, for those seeking a highly effective, less invasive option, semaglutide (Wegovy) offers a powerful medical alternative, providing a significant answer to the GLP1 weight loss vs surgery and diet question
For example, you can titrate in 0.125 mg or 0.25 mg increments rather than being limited to the fixed pen doses of brand-name products
1 2 Wang MD, Huang Y, Zhang GP, Mao L, Xia YP, Mei YW, Hu B (December 2012)
How insulin interacts with Ozempic: Ozempic can increase the risk of low blood sugar (hypoglycemia) when taken with insulin
PlexusDx Microdose Protocol: Personalized Low-Dose Starting Point PlexusDx Microdose GLP-1 Protocol begins at $129 per month and is designed for patients seeking a gentle entry into peptide therapy or those with genetic profiles associated with strong low-dose response
In March 2024, the Food and Drug Administration removed the specific BMI requirements from semaglutide's label, partly to correct for the limitations of BMI as a measurement tool, a metric that researchers had long argued was developed on European populations and doesn't translate well across different bodies